{"id":"https://openalex.org/W2983158288","doi":"https://doi.org/10.1093/neuonc/noz175.256","title":"COMP-13. EARLY TUMOR VOLUME EVOLUTION ADAPTIVELY PREDICTS PATIENT-SPECIFIC RESPONSE AND PROGRESSION RISK TO RADIOTHERAPY, PEMBROLIZUMAB, AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA IN A PHASE I TRIAL","display_name":"COMP-13. EARLY TUMOR VOLUME EVOLUTION ADAPTIVELY PREDICTS PATIENT-SPECIFIC RESPONSE AND PROGRESSION RISK TO RADIOTHERAPY, PEMBROLIZUMAB, AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA IN A PHASE I TRIAL","publication_year":2019,"publication_date":"2019-11-01","ids":{"openalex":"https://openalex.org/W2983158288","doi":"https://doi.org/10.1093/neuonc/noz175.256","mag":"2983158288"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noz175.256","doi":"https://doi.org/10.1093/neuonc/noz175.256","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/noz175.256","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6847129","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021309275","display_name":"Daniel J. Glazar","orcid":"https://orcid.org/0000-0003-3031-8629","observed_orcids":["https://orcid.org/0000-0003-3031-8629"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Glazar","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064973591","display_name":"Rene Brady","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rene Brady","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103009351","display_name":"Rachel Howard","orcid":"https://orcid.org/0000-0002-7934-5081","observed_orcids":["https://orcid.org/0000-0002-7934-5081"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel Howard","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112560159","display_name":"Daniel Grass","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Grass","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111534179","display_name":"John A. Arrington","orcid":"https://orcid.org/0000-0001-8478-7792","observed_orcids":["https://orcid.org/0000-0001-8478-7792"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Arrington","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102896019","display_name":"Michael Andrew Yu","orcid":"https://orcid.org/0000-0002-6911-3578","observed_orcids":["https://orcid.org/0000-0002-6911-3578"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Yu","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060435181","display_name":"Natarajan Raghunand","orcid":"https://orcid.org/0000-0002-8893-7687","observed_orcids":["https://orcid.org/0000-0002-8893-7687"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natarajan Raghunand","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025331599","display_name":"Solmaz Sahebjam","orcid":"https://orcid.org/0000-0001-9930-9937","observed_orcids":["https://orcid.org/0000-0001-9930-9937"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Solmaz Sahebjam","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014796235","display_name":"Heiko Enderling","orcid":"https://orcid.org/0000-0002-9696-6410","observed_orcids":["https://orcid.org/0000-0002-9696-6410"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heiko Enderling","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.15860986,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"Supplement_6","first_page":"vi63","last_page":"vi64"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7954000234603882,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7954000234603882,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.18490000069141388,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-high-grade-glioma","display_name":"recurrent high-grade glioma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8989999890327454},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/hypofractionated-stereotactic-radiotherapy","display_name":"hypofractionated stereotactic radiotherapy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/mathematical-tumor-growth-model","display_name":"mathematical tumor growth model","score":0.8450000286102295},{"id":"https://openalex.org/keywords/progression-risk-prediction","display_name":"progression risk prediction","score":0.8659999966621399},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.49399998784065247},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-combination-therapy","display_name":"immune checkpoint inhibitor combination","score":0.5910000205039978},{"id":"https://openalex.org/keywords/leave-one-out-cross-validation","display_name":"leave-one-out cross-validation","score":0.6470000147819519},{"id":"https://openalex.org/keywords/phase-i-trial-design","display_name":"phase I trial design","score":0.460999995470047},{"id":"https://openalex.org/keywords/rano-criteria","display_name":"RANO criteria","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8261393308639526},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7305587530136108},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.6495080590248108},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5909984111785889},{"id":"https://openalex.org/C2780387249","wikidata":"https://www.wikidata.org/wiki/Q973234","display_name":"Radiosurgery","level":3,"score":0.5530663728713989},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.5096123218536377},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4355587363243103},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4188389778137207},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.4179970324039459},{"id":"https://openalex.org/C101070640","wikidata":"https://www.wikidata.org/wiki/Q3737215","display_name":"Fluid-attenuated inversion recovery","level":3,"score":0.4130944609642029},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.32783010601997375},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2223246693611145},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.172650545835495},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1523665487766266},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.13485047221183777},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noz175.256","doi":"https://doi.org/10.1093/neuonc/noz175.256","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/noz175.256","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6847129","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6847129","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:6847129","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6847129","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3037264776","https://openalex.org/W2070747371","https://openalex.org/W3168186305","https://openalex.org/W2588175960","https://openalex.org/W7213726113","https://openalex.org/W4412717868","https://openalex.org/W2464058644","https://openalex.org/W4389411736","https://openalex.org/W2969255987","https://openalex.org/W7146067008"],"abstract_inverted_index":{"Abstract":[0],"PURPOSE/OBJECTIVES":[1],"We":[2,89,108],"set":[3],"out":[4],"to":[5,80,87,101,105,138,158,162,168,201,205,273,277],"predict":[6,102,274],"response":[7,86,104,128,166,197,276],"and":[8,23,83,119,122,125,155,173,187,194,231,239,243,245,251,279,293],"progression":[9,31,174,280],"risk":[10,281],"in":[11,35,61,260,289,296],"recurrent":[12],"high-grade":[13],"glioma":[14,191],"patients":[15,212],"treated":[16],"with":[17,47,213,223,229],"hypofractionated":[18],"stereotactic":[19],"radiation":[20],"plus":[21],"pembrolizumab":[22,121],"bevacizumab":[24,123],"(NCT02313272).":[25],"At":[26],"present":[27],"RANO":[28],"criteria":[29],"define":[30],"as":[32],"25%":[33],"increase":[34,60],"sum":[36],"of":[37,40,43,70,132,143,209,235,247],"the":[38,48,159,206],"products":[39],"perpendicular":[41],"diameters":[42],"enhancing":[44],"lesions":[45],"compared":[46],"smallest":[49],"tumor":[50,93,116,141,170,270],"measurement":[51],"(either":[52],"at":[53],"baseline":[54],"or":[55,58,67],"best":[56],"response)":[57],"significant":[59],"T2/FLAIR":[62],"non-enhancing":[63],"lesion":[64],"on":[65,182],"stable":[66],"increasing":[68],"doses":[69],"corticosteroids.":[71],"To":[72],"this":[73],"extent,":[74],"a":[75,98,110,147,261],"predictive":[76,233],"model":[77,100,112,151,263],"is":[78,179,287],"needed":[79],"adaptively":[81,163,266],"learn":[82,164],"forecast":[84,169],"individual":[85,283],"therapy.":[88,106],"evaluate":[90],"if":[91],"early":[92,269],"volume":[94,171,271],"evolution":[95,172,272],"can":[96,264],"train":[97],"mathematical":[99,111,262],"subsequent":[103,275],"MATERIALS/METHODS":[107],"develop":[109],"that":[113],"describes":[114],"patient-uniform":[115,150],"growth":[117,192],"rate":[118,193],"initial":[120,195],"responses,":[124],"patient-specific":[126,258],"treatment":[127,165,196],"dynamics.":[129],"A":[130],"total":[131],"154":[133],"radiology":[134],"scans":[135],"were":[136],"delineated":[137],"derive":[139],"longitudinal":[140,207],"volumes":[142],"26":[144],"patients.":[145,284],"In":[146],"leave-one-out":[148],"study,":[149],"parameters":[152,259],"are":[153,199,221],"derived":[154],"then":[156],"applied":[157],"left-out":[160],"patient":[161],"dynamics":[167,220],"risk.":[175],"Model":[176],"prediction":[177],"performance":[178],"evaluated":[180],"based":[181],"classification":[183],"accuracy,":[184],"including":[185],"sensitivity":[186,244],"specificity.":[188],"RESULTS":[189],"Patient-uniform":[190],"rates":[198],"estimated":[200],"achieve":[202],"acceptable":[203],"fits":[204],"data":[208],"all":[210],"untrained":[211],"R2":[214],"=":[215],"0.81":[216,240],"[0.75,":[217],"0.89].":[218],"Response":[219],"predicted":[222],"high":[224],"accuracy":[225],"(0.78":[226],"[0.76,":[227],"0.79]),":[228],"positive":[230],"negative":[232],"values":[234],"0.90":[236],"[0.86,":[237],"0.92]":[238],"[0.78,":[241],"0.86],":[242],"specificity":[246],"0.71":[248],"[0.69,":[249],"0.73]":[250],"0.88":[252],"[0.83,":[253],"0.91]":[254],"respectively.":[255],"CONCLUSIONS":[256],"Two":[257],"be":[265],"learned":[267],"from":[268],"therapy":[278],"for":[282],"Future":[285],"validation":[286],"required":[288],"an":[290],"independent":[291],"dataset":[292],"prospective":[294],"evaluation":[295],"another":[297],"clinical":[298],"trial.":[299]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-11-22T00:00:00"}